COM:ACTICOR-BIOTECH
Acticor Biotech
- Stock
Last Close
0.30
25/11 08:00
Market Cap
8.67M
Beta: -
Volume Today
50
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 66.72K - | 80.76K 21.05% | 80.60K 0.21% | 217.59K 169.97% | 180.57K 17.01% | |||||||
average payables | 5.67M - | 5.85M 3.19% | 5.94M 1.64% | 6.11M 2.74% | 3.74M 38.79% | 905.50K 75.77% | 1.07M 18.00% | 2.17M 102.99% | 2.87M 32.37% | 4.08M 42.25% | 6.50M 59.18% | |
average receivables | ||||||||||||
book value per share | 5.87 - | 5.57 4.97% | 5.16 7.34% | 5.02 2.75% | -1.22 124.28% | 0.59 148.50% | 0.86 44.83% | 0.16 81.00% | 1.42 770.30% | -0.21 115.02% | -0.44 106.98% | |
capex per share | -0.93 - | -0.63 31.97% | -0.80 26.69% | -0.34 57.38% | -0.13 63.14% | -0.01 95.63% | -0.00 70.69% | -0.01 211.76% | -0.00 66.75% | -0.00 65.95% | 0.00 391.28% | |
capex to depreciation | -5.08 - | -0.67 86.80% | -5.18 672.06% | -2.22 57.16% | -0.06 97.23% | -0.37 497.73% | -0.03 90.77% | -0.38 1,017.90% | -0.14 64.23% | -0.07 48.48% | 0.03 139.38% | |
capex to operating cash flow | -1.86 - | -0.51 72.68% | 1.02 301.15% | -1.66 262.05% | 2.57 255.46% | 0.01 99.59% | 0.00 62.47% | 0.01 97.79% | 0.00 87.98% | 0.00 47.57% | -0.00 409.91% | |
capex to revenue | -0.18 - | -0.11 39.65% | -0.16 47.06% | -0.08 47.56% | -0.05 42.22% | -1.16 2,354.05% | ||||||
cash per share | 1.71 - | 2.81 63.96% | 1.24 55.77% | 0.88 29.12% | 0.02 97.26% | 0.97 3,902.25% | 1.22 26.43% | 0.72 41.11% | 1.46 102.74% | 0.63 57.10% | 0.32 48.56% | |
days of inventory on hand | 2.80 - | 2.75 2.00% | 2.14 22.03% | 14.18 562.36% | ||||||||
days payables outstanding | 220.07 - | 184.31 16.25% | 174.45 5.35% | 242.52 39.02% | 67.03 72.36% | 3.94K - | ||||||
days sales outstanding | ||||||||||||
debt to assets | 0.05 - | 0.13 171.57% | 0.15 10.81% | 0.13 13.25% | 0.75 494.08% | 0.11 85.98% | 0.07 29.84% | 0.23 215.48% | 0.15 34.94% | 0.61 301.29% | 0.60 0.48% | |
debt to equity | 0.08 - | 0.22 172.91% | 0.26 14.47% | 0.22 15.18% | -0.39 277.82% | 0.19 149.86% | 0.13 34.58% | 1.49 1,088.10% | 0.25 83.56% | -3.51 1,526.83% | -1.11 68.46% | |
dividend yield | ||||||||||||
earnings yield | 0.08 - | -0.04 149.36% | -0.06 40.29% | -0.02 65.11% | -0.44 2,090.77% | -0.08 81.85% | -0.07 15.63% | -0.10 52.98% | -0.37 256.48% | -0.22 39.72% | -0.53 138.37% | |
enterprise value | 23.55M - | 24.17M 2.65% | 27.75M 14.79% | 24.87M 10.38% | 24.84M 0.12% | 65.36M 163.12% | 62.60M 4.22% | 69.32M 10.74% | 26.99M 61.06% | 75.72M 180.51% | 36.99M 51.15% | |
enterprise value over ebitda | 7.76 - | 11.21 44.42% | -19.67 275.46% | 191.87 1,075.58% | -8.20 104.28% | -11.52 40.40% | -13.42 16.55% | -9.33 30.52% | -2.27 75.71% | -5.04 122.40% | -2.20 56.40% | |
ev to operating cash flow | 14.20 - | 5.86 58.78% | -10.67 282.25% | 36.37 440.77% | -153.21 521.31% | -11.94 92.21% | -14.64 22.64% | -10.29 29.74% | -1.96 80.91% | -6.26 218.66% | -2.84 54.58% | |
ev to sales | 1.34 - | 1.22 8.93% | 1.63 33.24% | 1.80 10.27% | 2.81 56.58% | 1.31K 46,357.91% | ||||||
free cash flow per share | -0.43 - | 0.61 242.60% | -1.59 358.78% | -0.14 91.47% | -0.17 29.22% | -0.52 200.05% | -0.41 22.41% | -0.64 58.23% | -1.77 174.62% | -1.15 35.08% | -1.08 5.91% | |
free cash flow yield | -0.06 - | 0.09 242.60% | -0.23 358.78% | -0.02 91.47% | -0.02 29.22% | -0.07 200.05% | -0.06 22.41% | -0.09 58.23% | -0.39 322.72% | -0.16 57.89% | -0.37 129.05% | |
graham net net | -2.34 - | -1.09 53.51% | -2.66 144.41% | -2.67 0.54% | -1.82 31.80% | 0.48 126.12% | 0.62 29.74% | -0.16 126.34% | 0.58 454.26% | -0.81 241.25% | -0.92 13.40% | |
graham number | 8.83 - | 6.05 31.51% | 6.90 14.01% | 4.02 41.75% | 9.26 130.64% | 2.75 70.33% | 3.04 10.54% | 1.64 46.09% | 7.35 348.94% | 2.75 62.64% | 3.91 42.36% | |
income quality | 1.00 - | -4.27 528.02% | 1.92 144.89% | -1.45 175.37% | 0.02 101.08% | 0.91 5,745.32% | 0.85 7.43% | 0.88 4.10% | 1.09 23.80% | 0.76 30.10% | 0.70 8.38% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0.05 Infinity% | 0.06 39.78% | 0.04 38.38% | 0.06 38.15% | 0 100% | |
interest coverage | -8.95 - | -2.71 69.73% | -153.69 5,570.04% | -37.15 75.83% | -58.68 57.97% | -95.90 63.42% | -19.98 79.16% | -19.74 1.21% | -8.20 58.44% | |||
interest debt per share | 0.48 - | 1.24 159.34% | 1.38 11.27% | 1.13 18.31% | 0.49 56.74% | 0.13 73.73% | 0.12 9.73% | 0.25 115.93% | 0.42 69.34% | 0.82 92.80% | 0.66 18.83% | |
inventory turnover | 130.28 - | 132.94 2.04% | 170.51 28.26% | 25.74 84.90% | ||||||||
invested capital | 0.08 - | 0.22 172.91% | 0.26 14.47% | 0.22 15.18% | -0.39 277.82% | 0.19 149.86% | 0.13 34.58% | 1.49 1,088.10% | 0.25 83.56% | -3.51 1,526.83% | -121K 3,451,546.95% | |
market cap | 23.36M - | 23.36M 0% | 23.36M 0% | 23.36M 0% | 23.36M 0% | 74.35M 218.26% | 74.35M 0% | 74.35M 0% | 35.63M 52.07% | 74.45M 108.94% | 35.00M 52.99% | |
net current asset value | 2.76M - | 3.90M 41.33% | 449.74K 88.46% | -287.64K 163.96% | -4.08M 1,317.41% | 5.95M 245.87% | 8.09M 35.98% | 817K 89.90% | 10.01M 1,125.21% | -3.45M 134.46% | -5.77M 67.41% | |
net debt to ebitda | 0.06 - | 0.38 507.43% | -3.11 925.90% | 11.63 474.06% | -0.49 104.20% | 1.58 424.60% | 2.52 58.98% | 0.68 73.17% | 0.73 7.32% | -0.08 111.60% | -0.12 40.43% | |
net income per share | 0.59 - | -0.29 149.36% | -0.41 40.29% | -0.14 65.11% | -3.13 2,090.77% | -0.57 81.85% | -0.48 15.63% | -0.73 52.98% | -1.70 131.58% | -1.58 7.07% | -1.54 2.09% | |
operating cash flow per share | 0.50 - | 1.25 149.00% | -0.78 162.98% | 0.21 126.30% | -0.05 123.71% | -0.52 961.14% | -0.41 21.90% | -0.64 57.62% | -1.77 176.52% | -1.15 35.06% | -1.08 6.01% | |
payables turnover | 1.66 - | 1.98 19.40% | 2.09 5.65% | 1.51 28.07% | 5.45 261.80% | 0.09 - | ||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | 81.84 - | |||||||||||
return on tangible assets | 0.06 - | -0.03 151.69% | -0.05 46.57% | -0.02 63.30% | -4.99 30,044.28% | -0.53 89.47% | -0.34 34.49% | -0.75 118.04% | -0.77 2.56% | -1.36 76.81% | -1.92 41.05% | |
revenue per share | 5.29 - | 5.96 12.71% | 5.14 13.85% | 4.18 18.72% | 2.66 36.21% | 0.00 99.82% | ||||||
roe | 0.10 - | -0.05 151.95% | -0.08 51.41% | -0.03 64.12% | 2.57 9,122.50% | -0.96 137.43% | -0.56 41.74% | -4.50 705.28% | -1.20 73.39% | 7.42 718.72% | 3.51 52.69% | |
roic | 0.08 - | -0.04 151.55% | -0.06 32.70% | -0.02 69.93% | 4.15 24,401.22% | -0.78 118.86% | -0.48 38.58% | -1.74 262.88% | -0.90 48.14% | -2.82 211.70% | -28.15 898.57% | |
sales general and administrative to revenue | 31.06 - | |||||||||||
shareholders equity per share | 5.87 - | 5.57 4.97% | 5.16 7.34% | 5.02 2.75% | -1.22 124.28% | 0.59 148.50% | 0.86 44.83% | 0.16 81.00% | 1.42 770.30% | -0.21 115.02% | -0.44 106.98% | |
stock based compensation to revenue | 0.68 - | |||||||||||
tangible asset value | 19.44M - | 18.47M 4.97% | 17.11M 7.34% | 16.64M 2.75% | -4.04M 124.28% | 6.24M 254.34% | 8.32M 33.40% | 1.00M 87.94% | 10.30M 927.42% | -2.96M 128.69% | -5.31M 79.74% | |
tangible book value per share | 5.87 - | 5.57 4.97% | 5.16 7.34% | 5.02 2.75% | -1.22 124.28% | 0.59 148.50% | 0.79 33.40% | 0.10 87.94% | 1.42 1,388.96% | -0.28 119.79% | -0.44 57.06% | |
working capital | 2.87M - | 7.73M 169.83% | 5.06M 34.50% | 3.48M 31.24% | -2.61M 174.90% | 7.01M 368.90% | 9.29M 32.53% | 3.74M 59.78% | 12.82M 242.86% | 5.04M 60.71% | -143K 102.84% |
All numbers in EUR (except ratios and percentages)